2-Ethylhexyl trans-4-methoxycinnamate

Modify Date: 2025-08-21 15:17:52

2-Ethylhexyl trans-4-methoxycinnamate structure	Common Name	2-Ethylhexyl trans-4-methoxycinnamate
	CAS Number	83834-59-7	Molecular Weight	290.397
	Density	1.0±0.1 g/cm3	Boiling Point	405.3±20.0 °C at 760 mmHg
	Molecular Formula	C₁₈H₂₆O₃	Melting Point	N/A
	MSDS	Chinese USA	Flash Point	171.6±16.4 °C
	Symbol	GHS07	Signal Word	Warning

Name	4-Methoxycinnamic Acid 2-Ethylhexyl Ester
Synonym	More Synonyms

Density	1.0±0.1 g/cm3
Boiling Point	405.3±20.0 °C at 760 mmHg
Molecular Formula	C₁₈H₂₆O₃
Molecular Weight	290.397
Flash Point	171.6±16.4 °C
Exact Mass	290.188202
PSA	35.53000
LogP	5.66
Vapour Pressure	0.0±0.9 mmHg at 25°C
Index of Refraction	1.515

2-Ethylhexyl trans-4-methoxycinnamate MSDS(Chinese)

Symbol	GHS07
Signal Word	Warning
Hazard Statements	H315-H319-H335
Precautionary Statements	P261-P305 + P351 + P338
Personal Protective Equipment	Eyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
Hazard Codes	Xi: Irritant;
Risk Phrases	R36/37/38
Safety Phrases	24/25-36-26
RIDADR	NONH for all modes of transport

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

J. Sci. Ind. Res. 65(10) , 808, (2006)

Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ...

Developing structure-activity relationships for the prediction of hepatotoxicity.

Chem. Res. Toxicol. 23 , 1215-22, (2010)

Drug-induced liver injury is a major issue of concern and has led to the withdrawal of a significant number of marketed drugs. An understanding of structure-activity relationships (SARs) of chemicals ...

A predictive ligand-based Bayesian model for human drug-induced liver injury.

Drug Metab. Dispos. 38 , 2302-8, (2010)

Drug-induced liver injury (DILI) is one of the most important reasons for drug development failure at both preapproval and postapproval stages. There has been increased interest in developing predicti...

UNII:F547714O0V

2-Propenoic acid, 3-(4-methoxyphenyl)-, 2-ethylhexyl ester, (2Z)-

MFCD00072582

2-Ethylhexyl (2Z)-3-(4-methoxyphenyl)acrylate

4-methoxycinnamic acid 2-ethylhexyl ester

EINECS 226-775-7